BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6799680)

  • 1. Comparison of serum blocking factors on leucocyte adherence inhibition and PHA lymphocyte blastogenesis in breast cancer patients.
    Fujisawa T; Yonemoto RH; Waldman SR
    Jpn J Surg; 1981; 11(6):406-12. PubMed ID: 6799680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
    Tanaka F; Sawada K; Yonemoto RH
    Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
    Tsang PH; Roboz JP; Holland JF; Bekesi JG
    Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of serum factors and cell washings on leukocyte adherence inhibition in breast cancer patients.
    Fujisawa T; Waldman SR; Yonemoto RH
    Gan; 1980 Apr; 71(2):165-72. PubMed ID: 7009300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses in the treatment of advanced carcinoma of the breast. Effects of adrenalectomy.
    Yonemoto RH; Schick P; Albano W; Fujisawa T; Waldman SH
    Arch Surg; 1977 Aug; 112(8):991-6. PubMed ID: 327980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
    O'Connor R; MacFarlane JK; Murray D; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
    Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
    J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking factors in sera of breast cancer patients.
    Tanaka F; Yonemoto RH; Waldman SR
    Cancer; 1979 Mar; 43(3):838-47. PubMed ID: 427725
    [No Abstract]   [Full Text] [Related]  

  • 11. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
    Lopez M; O'Connor R; MacFarlane JK; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-populations involved in the humoral leukocyte adherence inhibition reaction. The T8-suppressor/cytotoxic cells are both effectors and responders.
    Moskaug JO; Kotlar HK; Sanner T
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):149-56. PubMed ID: 2965016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D; Kaufmann M; Drings P; Fedra G
    Oncology; 1978; 35(6):242-5. PubMed ID: 370704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
    Varga A; Stosiek P; Kasper M
    Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine ocular squamous-cell carcinoma: lymphocyte response to phytohaemagglutinin and tumour antigen.
    Jennings PA; Lavin MF; Hughes DJ; Spradbrow PB
    Br J Cancer; 1979 Oct; 40(4):608-14. PubMed ID: 497111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-antigen does not induce cell mediated immunity in patients with breast cancer.
    Howard DR
    Cancer; 1983 Jun; 51(11):2053-6. PubMed ID: 6839295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.